Home

UiPath, Inc. Class A Common Stock (PATH)

11.83
0.00 (0.00%)

UiPath Inc is a leading provider of artificial intelligence-powered robotic process automation (RPA) software that enables organizations to automate repetitive and mundane tasks, thereby increasing efficiency and productivity

By offering an intuitive platform that integrates with existing systems, UiPath empowers businesses to streamline their operations, reduce human error, and free up employees to focus on higher-value work. The company's solutions cater to various industries and help clients achieve digital transformation by automating workflow processes, data management, and customer interactions, ultimately driving better outcomes and enhancing operational agility.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close11.83
Open-
Bid9.710
Ask9.740
Day's RangeN/A - N/A
52 Week Range10.37 - 25.47
Volume91,764
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume10,130,369

News & Press Releases

UiPath (PATH) Q4 2025 Earnings Call Transcriptfool.com
PATH earnings call for the period ending December 31, 2024.
Via The Motley Fool · March 12, 2025
What's going on in today's after hours sessionchartmill.com
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · March 12, 2025
12 Information Technology Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · March 12, 2025
UiPath Shares Plunge After Q4 Revenues Miss, Weak Q1 Guidancebenzinga.com
UiPath releases its fourth-quarter results after Wednesday's closing bell. Here's a look at the key figures from the report.
Via Benzinga · March 12, 2025
UiPath (NYSE:PATH) Posts Q4 Sales In Line With Estimates But Stock Drops 17.4%
Automation software company UiPath (NYSEPATH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.5% year on year to $423.6 million. On the other hand, next quarter’s revenue guidance of $332.5 million was less impressive, coming in 10% below analysts’ estimates. Its non-GAAP profit of $0.26 per share was 34.1% above analysts’ consensus estimates.
Via StockStory · March 12, 2025
Should Investors Buy UiPath Stock?fool.com
Via The Motley Fool · March 8, 2025
Looking Into UiPath's Recent Short Interestbenzinga.com
Via Benzinga · February 11, 2025
UiPath Acquires Peak to Launch Vertically Specialized Agents within its Agentic Automation Platform
UiPath (NYSEPATH), a leading enterprise automation and AI software company, today announced the acquisition of Peak, an AI-native company based in Manchester, United Kingdom. The Peak AI platform optimizes product inventory and pricing for businesses of all sizes and across a wide range of industries, providing customers with tangible outcomes quickly and without the need for large, in-house tech teams.
By UiPath · Via Business Wire · March 12, 2025
UiPath Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
UiPath, Inc. (NYSEPATH), a leading enterprise automation and AI software company, today announced financial results for its fourth quarter and full year fiscal 2025 ended January 31, 2025.
By UiPath, Inc. · Via Business Wire · March 12, 2025
UiPath Stock Rises Ahead Of Q4 Results Due Wednesday: Retail’s Convinced Of Long-term Potentialstocktwits.com
UiPath’s guidance issued in early December calls for revenue of $422 million to $427 million and ARR of $1.669 billion to $1.674 billion.
Via Stocktwits · March 12, 2025
UiPath (PATH) Reports Earnings Tomorrow: What To Expect
Automation software company UiPath (NYSEPATH) will be reporting results tomorrow afternoon. Here’s what investors should know.
Via StockStory · March 11, 2025
Earnings Scheduled For March 12, 2025benzinga.com
Via Benzinga · March 12, 2025
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dipbenzinga.com
Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.
Via Benzinga · March 8, 2025
UiPath Expands Healthcare Automation with New Global Professional Services Capabilities for Electronic Medical Records Platform
UiPath (NYSEPATH), a leading enterprise automation and AI software company, today announced that it has negotiated a new global consulting agreement with a major Electronic Medical Records (EMR) platform to accelerate professional services programs for customers in 16 new countries. With the agreement, UiPath significantly expands its professional services capabilities for healthcare organizations and makes customer and partner access to this EMR platform faster and more seamless.
By UiPath · Via Business Wire · March 3, 2025
2 Undervalued Growth Stocks Investors Can Buy Right Now in 2025fool.com
Via The Motley Fool · February 18, 2025
Palantir Stock Is Up 585% Since Early 2024. History Is Clear About What Happens Next.fool.com
Via The Motley Fool · February 15, 2025
UiPath Announces Fourth Quarter and Full Year Fiscal 2025 Financial Results Conference Call
UiPath, Inc. (NYSEPATH), a leading enterprise automation and AI software company, today announced it will report financial results for its fourth quarter and full year fiscal 2025 ended January 31, 2025 after the market closes on Wednesday, March 12, 2025. Management will host a conference call and webcast to discuss the Company's financial results at 5:00 pm ET.
By UiPath, Inc. · Via Business Wire · February 12, 2025
UiPath to Showcase How Agentic Automation is Transforming the Healthcare Industry at ViVE 2025 Conference
UiPath (NYSEPATH), a leading enterprise automation and AI software company, today announced it is exhibiting at the ViVE 2025 conference in Nashville from February 17-19, 2025 to showcase how agentic automation is empowering healthcare organizations to streamline operations, improve outcomes, and unlock new levels of productivity. The company will exhibit its Agentic Automation capabilities at booth #738.
By UiPath · Via Business Wire · February 12, 2025
Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highsbenzinga.com
On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in the share price of the company.
Via Benzinga · February 10, 2025
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursdaybenzinga.com
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.
Via Benzinga · February 8, 2025
uiPath Stock Jumps On Positive In-House Report On Agentic AI Adoption: Retail Optimism Growsstocktwits.com
UiPath’s RPA tool uses software robots to automate repetitive tasks and it is deployed by small, midsize and enterprise businesses.
Via Stocktwits · January 28, 2025
UiPath Report Reveals Agentic AI is Driving Investment to Tackle More Complex Business Workflows
UiPath (NYSEPATH), a leading enterprise automation and AI software company, today released a new report that reveals 90% of IT executives have business processes that would be improved by agentic AI, while 77% state they are prepared to invest in agentic AI this year.
By UiPath · Via Business Wire · January 27, 2025
President Trump Unveils $500 Billion AI Infrastructure: Watch AI, PRSO, BBAI Among The Giants
In a groundbreaking move, former President Donald Trump has announced a sweeping plan to invest at least $500 billion into artificial intelligence (AI) infrastructure. This initiative, designed to cement the United States' position as a global leader in AI innovation, underscores a collaborative approach involving technology giants, mid-sized players, small-cap, and micro-cap disruptors across the sector.
Via AB Newswire · January 22, 2025
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policiesbenzinga.com
Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI.
Via Benzinga · January 22, 2025
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidiabenzinga.com
Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares.
Via Benzinga · January 18, 2025